Skip To Main Content
- Obe-cel on Muck Rack

- Obe-cel

As seen in: ADVFN
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to - Obe-cel’s profile

Articles by - Obe-cel

Syncona Limited Autolus reports Q3 2023 Financial Results (2145S)

|
By - Obe-cel, September December, Equipment - -
| ADVFN
Share Name Share Symbol Market Type Share ISIN Share Description Syncona Limited LSE:SYNC London Ordinary Share GG00B8P59C08 ORD NPV Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 3.80 2.95% 132.80 132.40 132.80 132.80 130.00 130.00 139,907 11:11:08 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Trust,ex Ed,religious,charty -39.8 -56.0 -8.4 - 885.42 Syncona (LSE:SYNC) Intraday Stock Chart Thursday 2...
Open in Who Shared View Duplicates (107) Issue with article?

Syncona Limited Portfolio Update

|
By - Obe-cel
| ADVFN
Syncona (LSE:SYNC) Intraday Stock Chart Thursday 3 August 2023 TIDMSYNC RNS Number : 2247I Syncona Limited 03 August 2023 Syncona Limited Autolus reports second quarter 2023 Financial Results and Operational Progress 3 August 2023 Syncona Ltd, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, notes that its portfolio company, Autolus Therapeutics Plc (NASDAQ: AUTL) (Autolus), announced its operational and financial results...
Open in Who Shared View Duplicates (29) Issue with article?

Syncona Limited Autolus reports Q1 2023 Financial Results

|
By - Obe-cel
| ADVFN
Syncona (LSE:SYNC) Intraday Stock Chart Thursday 4 May 2023 TIDMSYNC RNS Number : 4442Y Syncona Limited 04 May 2023 Syncona Limited Autolus reports first quarter 2023 Financial Results and Operational Progress 4 May 2023 Syncona Ltd, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, notes that its portfolio company, Autolus Therapeutics Plc (NASDAQ: AUTL) (Autolus), announced its operational and financial results for the...
Open in Who Shared View Duplicates (33) Issue with article?
Show More